# An Exploratory Study of 18F-Labeled Hydroxyphenethylguanidines in Heart Failure Patients

> **NCT02669563** · EARLY_PHASE1 · COMPLETED · sponsor: **University of Michigan** · enrollment: 16 (actual)

## Conditions studied

- Cardiomyopathy

## Interventions

- **DRUG:** [18F]4F-MHPG
- **DRUG:** [18F]3F-PHPG
- **DRUG:** [13N]ammonia
- **DRUG:** [11C]HED

## Key facts

- **NCT ID:** NCT02669563
- **Lead sponsor:** University of Michigan
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-12
- **Primary completion:** 2016-08
- **Final completion:** 2016-12
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2017-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02669563

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02669563, "An Exploratory Study of 18F-Labeled Hydroxyphenethylguanidines in Heart Failure Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02669563. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*